Viewing Study NCT01853033


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-03-01 @ 12:04 PM
Study NCT ID: NCT01853033
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2013-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tolerability View
None Immunogenicity View
None Safety View
None Rheumatoid Arthritis View
None Pharmacokinetics View